During the past decade, Louisiana Center for Advanced Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana Center for Advanced Medicine" #1 collaborator was "LFB USA, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana Center for Advanced Medicine" are "Hemophilia A With Inhibitor" (1 trials), "Hemophilia B" (1 trials) and "Hemophilia B With Inhibitor" (1 trials). Many other conditions were trialed in "Louisiana Center for Advanced Medicine" in a lesser frequency.

Most popular intervention types in "Louisiana Center for Advanced Medicine" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "PF-06838435 (formerly SPK-9001)" (1 trials) and "coagulation factor VIIa [recombinant]-jncw" (1 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana Center for Advanced Medicine" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Louisiana Center for Advanced Medicine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Louisiana Center for Advanced Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana Center for Advanced Medicine, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".